Table 1.
Demographics.
| No GVHD arm (27) | GVHD arm (24) | |
|---|---|---|
| Median age | 41 | 42 |
| Females/Males | 11F/16M | 8F/16M |
| Ethnic | 26W/1Asian | 21W/3AA |
| Diagnosis: | ||
| DLBC NHL | 15 | 12 |
| HL | 10 | 6 |
| Anaplastic NHL | 0 | 2 |
| Angioimmunoblastic NHL | 0 | 2 |
| NK NHL | 1 | 0 |
| Burkitt's NHL | 1 | 0 |
| Hepatosplenic NHL | 0 | 1 |
| Follicular Grade 3 NHL | 0 | 1 |
| Conditioning regimen | 17 Bu-Cy/10 Cy-TBI | 15 Bu-Cy/9 Cy-TBI |
| Bone marrow involvement | 3 | 4 (1 unknown) |
| Failed to achieve a PR to salvage therapy following relapse | 14 | 12 |
| Progressive disease less than 6 weeks after completing induction | 13 | 12 |
Characteristics of patients enrolled in study. W: white, AA: African-American, DLBC: diffuse large cell, NHL: non-Hodgkin lymphoma, HL: Hodgkin lymphoma, XRT: radiation therapy, PR: partial response, Bu-Cy: busulfan and cyclophosphamide, Cy-TBI: cyclophosphamide and total body irradiation.